Nxera Pharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Public Companies | 1,885,136 | 2.1% |
VC/PE Firms | 5,610,000 | 6.24% |
Hedge Funds | 7,296,400 | 8.12% |
Individual Insiders | 7,444,223 | 8.28% |
Institutions | 20,663,037 | 23% |
General Public | 47,002,310 | 52.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
7,296,400 | US$53.3m | 14.6% | 4.41% | |||
6,630,000 | US$48.5m | 0% | no data | |||
5,610,000 | US$41.0m | 0% | no data | |||
3,885,702 | US$28.4m | 0% | no data | |||
3,004,300 | US$22.0m | 13.5% | 0.01% | |||
2,980,100 | US$21.8m | 2.71% | no data | |||
2,340,800 | US$17.1m | 0% | 0.02% | |||
2,288,259 | US$16.7m | -14.1% | 0.01% | |||
1,885,136 | US$13.8m | 0% | no data | |||
1,662,100 | US$12.2m | -4.33% | 0.01% | |||
1,495,183 | US$10.9m | 0% | 0.01% | |||
1,357,300 | US$9.9m | -1.19% | no data | |||
1,303,300 | US$9.5m | 0% | no data | |||
1,300,900 | US$9.5m | -2.24% | 0.01% | |||
991,837 | US$7.3m | 0% | 0.38% | |||
887,339 | US$6.5m | 0% | no data | |||
594,270 | US$4.3m | 0% | no data | |||
164,587 | US$1.2m | 0% | no data | |||
147,136 | US$1.1m | 0% | no data | |||
144,555 | US$1.1m | 0% | 0.06% | |||
127,500 | US$932.1k | 0% | no data | |||
119,900 | US$876.6k | 0% | no data | |||
110,000 | US$804.2k | 0% | no data | |||
82,985 | US$606.7k | 0% | no data | |||
71,200 | US$520.5k | 0% | no data |